Haag GM, Springfeld C, Grun B, Apostolidis L, et al. Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer - The PICCASSO phase I trial. Eur J Cancer 2022;167:112-122.
PMID: 35427833